Please provide your email address to receive an email when new articles are posted on . IVIG had favorable effects on skin thickening, muscle and joint pain, and gastrointestinal symptoms of systemic ...

Please provide your email address to receive an email when new articles are posted on . In a case study of three patients with COVID-19 vaccine-induced immune thrombotic thrombocytopenia, starting ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Did you know that a component of your blood could be used ...

BOSTON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Research published in the prestigious Proceedings of the National Academy of Sciences of the United States of America (PNAS) offers hope for long-term ...

Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently ...

March 26, 2012 — The American Academy of Neurology (AAN) has published an evidence-based guideline on the use of intravenous immunoglobulin (IVIg) in the treatment of neuromuscular disorders.

NORFOLK, Va. — After a nationwide shortage of intravenous immunoglobulin (IVIG) medication, medical centers are now getting it back in stock. Patients at Sentara Health Care can now receive their ...

Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently ...

Neurologists have reported new findings from the Phase 3 clinical trial of IVIG (intravenous immunoglobulin) in mild to moderate Alzheimer's disease. While the primary study outcomes were negative, ...

Vancouver, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The global Intravenous Immunoglobulin (IVIG) market size was USD 12.10 Billion in 2022 and is expected to register a revenue CAGR of 7.5% during the ...

Intravenous immunoglobulin (IVIg) has been evaluated as an adjunctive therapy for neonatal sepsis with modest clinical success despite strong biological plausibility. Multiple factors contribute to ...